DocGo (NASDAQ:DCGO) Price Target Lowered to $8.00 at Stifel Nicolaus

DocGo (NASDAQ:DCGO - Free Report) had its price objective trimmed by Stifel Nicolaus from $11.00 to $8.00 in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other research analysts have also weighed in on DCGO. BTIG Research dropped their target price on DocGo from $13.00 to $11.00 and set a buy rating on the stock in a research report on Wednesday. Canaccord Genuity Group dropped their target price on DocGo from $11.00 to $10.00 and set a buy rating on the stock in a research report on Thursday, February 29th. Needham & Company LLC dropped their target price on DocGo from $14.00 to $10.00 and set a buy rating on the stock in a research report on Thursday, February 29th. Finally, Cantor Fitzgerald dropped their target price on DocGo from $13.00 to $11.00 and set an overweight rating on the stock in a research report on Thursday, February 29th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of Buy and a consensus price target of $11.00.

DocGo Price Performance

DocGo stock traded down $0.50 during mid-day trading on Wednesday, hitting $3.35. The company's stock had a trading volume of 4,147,695 shares, compared to its average volume of 1,621,403. The firm's 50 day moving average is $3.74 and its 200 day moving average is $4.72. The company has a market cap of $348.97 million, a PE ratio of 47.86, a price-to-earnings-growth ratio of 0.37 and a beta of 0.91. DocGo has a 52-week low of $2.78 and a 52-week high of $10.82.

DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.07). The business had revenue of $199.25 million during the quarter, compared to analysts' expectations of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. As a group, analysts forecast that DocGo will post 0.36 EPS for the current year.

Insider Activity

In other DocGo news, Director Michael J. Burdiek bought 10,000 shares of the stock in a transaction on Thursday, March 14th. The shares were purchased at an average price of $3.61 per share, with a total value of $36,100.00. Following the acquisition, the director now directly owns 571,595 shares of the company's stock, valued at approximately $2,063,457.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 13.78% of the stock is currently owned by insiders.

Institutional Trading of DocGo

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DCGO. The Manufacturers Life Insurance Company lifted its position in shares of DocGo by 3.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 31,603 shares of the company's stock worth $223,000 after acquiring an additional 1,135 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of DocGo by 8.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,617 shares of the company's stock worth $136,000 after acquiring an additional 1,174 shares during the period. Legal & General Group Plc lifted its position in shares of DocGo by 4.1% in the 4th quarter. Legal & General Group Plc now owns 33,116 shares of the company's stock worth $234,000 after acquiring an additional 1,303 shares during the period. Victory Capital Management Inc. lifted its position in shares of DocGo by 6.3% in the 4th quarter. Victory Capital Management Inc. now owns 22,010 shares of the company's stock worth $220,000 after acquiring an additional 1,312 shares during the period. Finally, Arizona State Retirement System lifted its position in shares of DocGo by 8.3% in the 3rd quarter. Arizona State Retirement System now owns 26,516 shares of the company's stock worth $141,000 after acquiring an additional 2,042 shares during the period. Institutional investors and hedge funds own 56.44% of the company's stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.